Oscar Health (NYSE:OSCR) Shares Up 4.1% – Should You Buy?

Oscar Health, Inc. (NYSE:OSCR)’s stock price was up 4.1% during trading on Wednesday . The stock traded as high as $15.18 and last traded at $14.98. Approximately 739,484 shares were traded during trading, a decline of 67% from the average daily volume of 2,250,402 shares. The stock had previously closed at $14.39.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on OSCR. UBS Group started coverage on Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler restated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target on the stock. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $21.56.

Oscar Health Trading Up 4.4 %

The company has a fifty day moving average price of $15.24 and a 200-day moving average price of $16.94. The firm has a market capitalization of $3.72 billion, a price-to-earnings ratio of -250.46 and a beta of 1.70. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same period in the prior year, the firm earned ($0.29) EPS. Oscar Health’s quarterly revenue was up 68.3% on a year-over-year basis. On average, equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Buying and Selling at Oscar Health

In related news, Vice Chairman Joshua Kushner bought 276,040 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. This represents a 5.80 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Steven Wolin sold 19,580 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $354,006.40. Following the completion of the sale, the chief operating officer now owns 102,598 shares in the company, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Wealth Enhancement Advisory Services LLC raised its holdings in Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after purchasing an additional 844 shares during the last quarter. Summit Trail Advisors LLC lifted its holdings in Oscar Health by 5.4% in the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after buying an additional 1,065 shares during the period. KBC Group NV boosted its stake in Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares during the last quarter. Arizona State Retirement System grew its holdings in Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock worth $602,000 after acquiring an additional 1,351 shares during the period. Finally, Amalgamated Bank raised its position in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after acquiring an additional 1,458 shares during the last quarter. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.